Cannabix Technologies Announces First Commercial Delivery of Marijuana Breath Test to Construction Industry
VANCOUVER, British Columbia – Cannabix Technologies Inc., a developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement applications, has achieved a significant milestone with its first commercial sale of Marijuana Breath Test (MBT) products. The groundbreaking devices have been delivered to a major construction company operating in the Pacific Northwest region through an authorized reseller.
Addressing Critical Safety Needs in High-Risk Industries
The construction sector represents one of the most hazardous work environments across all U.S. industries, with workplace injury rates consistently ranking among the highest. This safety challenge has become increasingly complex with the growing prevalence of cannabis use across North America. The client company—a substantial regional contractor engaged in industrial, civil, and commercial construction projects—specifically sought next-generation technology to enhance workplace safety protocols by accurately identifying recent cannabis consumption among employees.
Safety-sensitive environments such as active construction sites, heavy equipment operations, and high-risk trades require sophisticated tools that enable employers to distinguish between recent cannabis use that could impair job performance and historical consumption during leisure time. Traditional drug testing methods have proven inadequate for these modern workplace challenges.
The Limitations of Conventional Drug Testing
Existing drug detection technologies—including urine, saliva, and hair testing—suffer from fundamental limitations that reduce their effectiveness in workplace safety applications:
- These methods primarily detect past cannabis use rather than recent consumption, often identifying cannabis metabolites from usage that occurred days or even weeks earlier
- They provide limited correlation to impairment-relevant timeframes, diminishing their utility for making real-time safety decisions about employee fitness for duty
- They create significant legal and labor-relations complications in jurisdictions where recreational and medical cannabis have been legalized, potentially penalizing employees for lawful off-duty behavior
Industries such as construction, transportation, logistics, warehousing, and manufacturing face disproportionate impacts from these limitations. These sectors operate under stringent safety regulations while simultaneously confronting persistent labor shortages. Employers across these fields are actively seeking fair, modern, and legally defensible approaches to managing cannabis-related risks without unfairly sanctioning employees for lawful activities conducted outside work hours.
MBT Technology: A Purpose-Built Solution
The Cannabix Marijuana Breath Test directly addresses this longstanding gap in workplace safety technology. The system detects delta-9 THC—the primary psychoactive component in cannabis—in breath samples within approximately four hours of consumption at concentration levels exceeding 5 picograms per liter. This detection window aligns closely with impairment-relevant timeframes, providing employers with actionable data that legacy testing methods cannot deliver.
The MBT incorporates Cannabix's proprietary Breath Collection Unit (BCU) and Breath Cartridge technologies, which collect and preserve breath samples for subsequent laboratory analysis using gold-standard liquid chromatography-mass spectrometry (LC-MS) methodologies. This sophisticated approach represents a significant advancement over traditional drug testing techniques.
Comprehensive Testing System Components
The complete MBT system includes several key components:
- The Cannabix Breath Collection Unit (BCU), which serves as the primary hardware for sample collection
- Single-use, disposable Breath Cartridges designed for individual testing applications
- The Laboratory Developed Test (LDT) Method developed and implemented by Omega Laboratories
Cannabix maintains a strategic partnership with Omega Laboratories Inc., a global leader in forensic drug testing with more than 25 years of industry experience. Omega operates a world-class accredited laboratory with extensive expertise in novel detection technologies, ensuring the highest standards of accuracy and reliability for the MBT system.
This first commercial delivery to the construction industry marks a pivotal moment in workplace safety technology, offering employers a scientifically validated tool for addressing cannabis-related impairment concerns while respecting employee rights in jurisdictions where cannabis has been legalized.
